Smallpox Discovery Prompts FDA Action Plan; Move To White Oak Unchanged

FDA scientist’s discovery of decades-old vials of smallpox at lab on NIH campus are a reminder of the unsettled debate on whether governments should keep smallpox stock to aid development of antivirals.